This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

EARLY SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
7-9 March 2023
Westin Miyako KyotoKyoto, Japan
REGISTER NOW
Menu
Sign Up
Key Sessions
Hiroaki Suga, Ph.D.
The Display for Pseudo-Natural Products
University of Tokyo, Japan
Shuling Guo, PhD
RNA Therapeutics: A Versatile Drug Discovery Platform
Ionis Pharmaceuticals, Inc.
David Craik, PhD
Using Plants as Biofactories to Produce Therapeutic Peptides
University of Queensland
Vasant Jadhav, PhD
RNAi in the Era of Nucleic Acid-based Therapeutics
Alnylam Pharmaceuticals
Satoshi Obika, PhD
Recent Progress in the Development of Bridged Nucleic Acids
Osaka University
keyboard_arrow_right

Day 1 - JST (Japan Standard Time, GMT+9)

keyboard_arrow_leftSearch & Filter
search

Day 1 - JST (Japan Standard Time, GMT+9)

search
8:00am - 9:00am60 mins
Registration and Coffee
    Optional Pre-Conference Workshops
    9:00am - 9:15am15 mins
    Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
    Workshop Moderator’s Opening Remarks
    • Bruce Morimoto, PhD - Vice President, Drug Development, Alto Neuroscience
    9:15am - 9:45am30 mins
    Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
    Advantages of Using Cyclic Peptides as Therapeutics with a Focus on Improving the Properties of Therapeutic Peptides
    • David Craik, PhD - Professor of Biomolecular Structure, Institute for Molecular Bioscience, University of Queensland
    9:45am - 10:45am60 mins
    Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
    Enhancing Peptide Properties by Side-chain and Structural Modification
    • Alastair Hay, PhD - Vice President, Peptides, Almac
    10:45am - 11:15am30 mins
    Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
    Networking Refreshment Break
      11:15am - 12:00pm45 mins
      Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
      Insights into Cell Penetration: Cyclic Davunetide As a Model System
      • Bruce Morimoto, PhD - Vice President, Drug Development, Alto Neuroscience
      12:00pm - 12:45pm45 mins
      Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
      Current Chemical Strategies in Extending Half-Lives of Therapeutic Peptides
      • El Djouhar Rekaï, PhD - Head of Business Unit Peptide Process Development, PolyPeptide Group
      1:55pm - 2:00pm5 mins
      Main Conference Plenary Keynote Session
      Chairperson’s Remarks
        2:00pm - 2:30pm30 mins
        Main Conference Plenary Keynote Session
        The Display for Pseudo-Natural Products
        • Hiroaki Suga, Ph.D. - Professor of Chemistry, School of Science, University of Tokyo, Japan
        2:30pm - 3:00pm30 mins
        Main Conference Plenary Keynote Session
        RNA Therapeutics: A Versatile Drug Discovery Platform
        • Shuling Guo, PhD - Vice President, Antisense Drug Discovery, Ionis Pharmaceuticals, Inc.
        3:00pm - 3:30pm30 mins
        Main Conference Plenary Keynote Session
        Using Plants as Biofactories to Produce Therapeutic Peptides
        • David Craik, PhD - Professor of Biomolecular Structure, Institute for Molecular Bioscience, University of Queensland
        3:30pm - 4:00pm30 mins
        Main Conference Plenary Keynote Session
        Networking Refreshment Break
          4:00pm - 4:30pm30 mins
          Main Conference Plenary Keynote Session
          RNAi in the Era of Nucleic Acid-based Therapeutics
          • Vasant Jadhav, PhD - Senior Vice President, Head of RNAi Platform, Alnylam Pharmaceuticals
          4:30pm - 5:00pm30 mins
          Main Conference Plenary Keynote Session
          Recent Progress in the Development of Bridged Nucleic Acids
          • Satoshi Obika, PhD - Professor, Graduate School of Pharmaceutical Sciences, Osaka University
          NextDay 2
          Filter
          Streams
          Choose Day